Category: Resources

Wellesley Institute & Upstream Report: Access to Housing: Federal Election 2015 Health Equity Impact Assessment

Posted On: Monday, October 5th, 2015

One in eight Canadian households live in housing that is either unaffordable, in disrepair, or crowded. In large cities such as Toronto, and amongst particular populations such as Aboriginal Peoples and recent immigrants, this ratio is even higher. Affordability is being threatened as the costs of housing increase faster than many incomes. As well, few… Read more »

The AIDS Vancouver Helpline is Growing – Help Spread the Word!

Posted On: Monday, October 5th, 2015

With a 44% increase in calls to the HIV Helpline we’re ready to call our new toll free service, 1-844-HIV-INFO, a huge success. Our continuing goal is to reduce barriers to those looking for answers regarding their sexual health, and the influx of callers from Canada and the U.S. has shown that providing toll-free access… Read more »

CHABAC Fact Sheet on HIV Stigma in African, Caribbean and Black Communities

Posted On: Monday, September 28th, 2015

CHABAC has released a fact sheet on HIV Stigma in African, Caribbean and Black Communities. People from African, Caribbean and Black (ACB) communities face multiple forms of stigma and discrimination. HIV-related stigma is just one of these. The purpose of this fact sheet is to raise awareness among health and social service professionals about the… Read more »

PWN – New brochure explains Canadian law on sex and HIV disclosure

Posted On: Monday, September 28th, 2015

When it comes to HIV disclosure, the law is complicated. In 2012, the Canadian Supreme Court issued a regressive ruling that made the law stricter for people living with HIV, in opposition to scientific assessments of risk and medical advancements that reduce the likelihood of transmission. Legally, people living with HIV must use a condom… Read more »

CATIE HepCinfo Update 6.17

Posted On: Sunday, September 27th, 2015

New and Noteworthy Daclatasvir approved in Canada The Hep C drug daclatasvir (Daklinza) has been approved in Canada for people with genotype 1 or 2 virus. It has also been conditionally approved for people with genotype 3 virus pending the outcome of a late-stage clinical trial. Daclatasvir is taken with sofosbuvir (Sovaldi) for 12 weeks… Read more »

OHTN – Health literacy, sexual health and gay men

Posted On: Tuesday, September 22nd, 2015

Working with collaborators from British Columbia, the OHTN’s Applied Epidemiology Unit has released a new report on health literacy, sexual health and gay men. Health literacy means having the skills to find, understand, evaluate and talk about health information with others. In Canada, gay men were one of the first groups affected by HIV, and they… Read more »

CATIE News – Study finds large savings from investment in community-based HIV prevention programs

Posted On: Monday, September 14th, 2015

Chronic illness can have a huge impact on the economies of cities, regions and countries. Researchers in the U.S. have estimated that the lifetime cost of care for HIV can range from about $250,000 to $400,000 per person. One way to reduce healthcare costs is to invest in disease prevention programs delivered through community-based organizations…. Read more »

CTAC Resource – Harvoni & Holkira Pak coverage in Canada

Posted On: Tuesday, September 8th, 2015

CTAC is pleased to share with you a preview of the treatment access information that will be contained in our soon to be launched Treatment Access Map (TxMAP).  Using data pulled from the TxMAP database we have created this one-page resource that outlines the public drug coverage under provincial and territorial formularies for Harvoni and… Read more »